Terkko Navigator / -/ Feeds / " ( ( Simvastatiini )|( SIMVASTATIN MYLAN )|( SIMVASTATIN AVANSOR )|( SIMVASTATIINI ENNAPHA"

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent

Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms

Simvastatin profoundly impairs energy metabolism in primary human muscle cells

Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.

Simvastatin protects against multiple low dose streptozotocin induced type 1 diabetes in CD-1 mice and recurrence of disease in non obese diabetic mice.

Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor KLF-2.

Simvastatin Decreases Lipopolysaccharide Induced Pulmonary Inflammation in Healthy Volunteers.

Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.

Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.

Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.

Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy.

Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion.

Simvastatin Treatment Upregulates Anti-Fibrotic Bone Morphogenetic Protein-7 Expression at Rat Cardiac Allograft Rejection.

Simvastatin pre-treatment improves survival and mitochondrial function in a three-day fluid-resuscitated rat model of sepsis.

Simvastatin Treatment Upregulates Anti-Fibrotic Bone Morphogenetic Protein-7 Expression at Rat Cardiac Allograft Rejection.

Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion.

Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression.

Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.

Simvastatin Posttreatment Controls Inflammation and Improves Bacterial Clearance in Experimental Sepsis

Simvastatin is a potential candidate drug in ovarian clear cell carcinomas.

Simvastatin affects Nrf2/MAPK signaling pathway and hepatic histological structure change in Gambusia affinis.

Simvastatin-Loaded Nanomicelles Enhance the Osteogenic Effect of Simvastatin

Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1.

Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial

Simvastatin profoundly impairs energy metabolism in primary human muscle cells.

Simvastatin profoundly impairs energy metabolism in primary human muscle cells.

Simvastatin profoundly impairs energy metabolism in primary human muscle cells.

Simvastatin treatment varies the radiation response of human breast cells in 2D or 3D culture

Simvastatin protects heart function and myocardial energy metabolism in pulmonary arterial hypertension induced right heart failure

Simvastatin profoundly impairs energy metabolism in primary human muscle cells

Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves’ Ophthalmopathy through the Regulation of FoxO3a Signaling

Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.

Simvastatin profoundly impairs energy metabolism in primary human muscle cells

Simvastatin profoundly impairs energy metabolism in primary human muscle cells

Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion

Simvastatin Treatment Upregulates Anti-Fibrotic Bone Morphogenetic Protein-7 Expression at Rat Cardiac Allograft Rejection

Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion

Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury

Simvastatin inhibits the inflammation and oxidative stress of human neutrophils in sepsis via autophagy induction

Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism

Simvastatin pre-treatment improves survival and mitochondrial function in a 3-day fluid-resuscitated rat model of sepsis

Materials, Vol. 13, Pages 4679: Simvastatin Induces In Vitro Mineralization Effects of Primary Human Odontoblast-Like Cells

Pharmaceutics, Vol. 13, Pages 138: Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment

Pharmaceutics, Vol. 14, Pages 1024: Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells

ZOCOR (simvastatin) tablet, film coated [Merck Sharp & Dohme Corp.]

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.

Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid.

Protective effects of simvastatin on coronary artery function in swine with acute infection.